 | • レポートコード：MRC2-11QY11900 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は外部神経調節のグローバル市場について調査・分析したレポートです。種類別（経皮的電気刺激、経頭蓋磁気刺激、呼吸器電気刺激）市場規模、用途別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別外部神経調節の競争状況、市場シェア ・世界の外部神経調節市場：種類別市場規模 2015年-2020年（経皮的電気刺激、経頭蓋磁気刺激、呼吸器電気刺激） ・世界の外部神経調節市場：種類別市場規模予測 2021年-2026年（経皮的電気刺激、経頭蓋磁気刺激、呼吸器電気刺激） ・世界の外部神経調節市場：用途別市場規模 2015年-2020年（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他） ・世界の外部神経調節市場：用途別市場規模予測 2021年-2026年（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他） ・北米の外部神経調節市場分析：米国、カナダ ・ヨーロッパの外部神経調節市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの外部神経調節市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の外部神経調節市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの外部神経調節市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Medtronic, Inc. (US)、Boston Scientific Corporation (US)、St. Jude Medical, Inc. (US)、Synapse Biomedical, Inc. (US)、Nevro Corporation (US)、Neurosigma, Inc. (US)、Neuropace, Inc. (US)、Neuronetics, Inc. (US)、Cyberonics, Inc. (US)、BioControl Medical (Israel) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global External Neuromodulation Market
The global External Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global External Neuromodulation Scope and Market Size
External Neuromodulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global External Neuromodulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Market segment by Type, the product can be split into
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Market segment by Application, split into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by External Neuromodulation Revenue
1.4 Market by Type
1.4.1 Global External Neuromodulation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transcutaneous Electrical Nerve Stimulation
1.4.3 Transcranial Magnetic Stimulation
1.4.4 Respiratory Electrical Stimulation
1.5 Market by Application
1.5.1 Global External Neuromodulation Market Share by Application: 2020 VS 2026
1.5.2 Spinal Cord Stimulation
1.5.3 Deep Brain Stimulation
1.5.4 Sacral Nerve Stimulation
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2015-2026)
2.2 Global External Neuromodulation Growth Trends by Regions
2.2.1 External Neuromodulation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 External Neuromodulation Historic Market Share by Regions (2015-2020)
2.2.3 External Neuromodulation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 External Neuromodulation Market Growth Strategy
2.3.6 Primary Interviews with Key External Neuromodulation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Market Size
3.1.1 Global Top External Neuromodulation Players by Revenue (2015-2020)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2015-2020)
3.1.3 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global External Neuromodulation Market Concentration Ratio
3.2.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2019
3.3 External Neuromodulation Key Players Head office and Area Served
3.4 Key Players External Neuromodulation Product Solution and Service
3.5 Date of Enter into External Neuromodulation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global External Neuromodulation Historic Market Size by Type (2015-2020)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global External Neuromodulation Market Size by Application (2015-2020)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America External Neuromodulation Market Size (2015-2020)
6.2 External Neuromodulation Key Players in North America (2019-2020)
6.3 North America External Neuromodulation Market Size by Type (2015-2020)
6.4 North America External Neuromodulation Market Size by Application (2015-2020)
7 Europe
7.1 Europe External Neuromodulation Market Size (2015-2020)
7.2 External Neuromodulation Key Players in Europe (2019-2020)
7.3 Europe External Neuromodulation Market Size by Type (2015-2020)
7.4 Europe External Neuromodulation Market Size by Application (2015-2020)
8 China
8.1 China External Neuromodulation Market Size (2015-2020)
8.2 External Neuromodulation Key Players in China (2019-2020)
8.3 China External Neuromodulation Market Size by Type (2015-2020)
8.4 China External Neuromodulation Market Size by Application (2015-2020)
9 Japan
9.1 Japan External Neuromodulation Market Size (2015-2020)
9.2 External Neuromodulation Key Players in Japan (2019-2020)
9.3 Japan External Neuromodulation Market Size by Type (2015-2020)
9.4 Japan External Neuromodulation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia External Neuromodulation Market Size (2015-2020)
10.2 External Neuromodulation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia External Neuromodulation Market Size by Type (2015-2020)
10.4 Southeast Asia External Neuromodulation Market Size by Application (2015-2020)
11 India
11.1 India External Neuromodulation Market Size (2015-2020)
11.2 External Neuromodulation Key Players in India (2019-2020)
11.3 India External Neuromodulation Market Size by Type (2015-2020)
11.4 India External Neuromodulation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America External Neuromodulation Market Size (2015-2020)
12.2 External Neuromodulation Key Players in Central & South America (2019-2020)
12.3 Central & South America External Neuromodulation Market Size by Type (2015-2020)
12.4 Central & South America External Neuromodulation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Medtronic, Inc. (US)
13.1.1 Medtronic, Inc. (US) Company Details
13.1.2 Medtronic, Inc. (US) Business Overview
13.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
13.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2015-2020))
13.1.5 Medtronic, Inc. (US) Recent Development
13.2 Boston Scientific Corporation (US)
13.2.1 Boston Scientific Corporation (US) Company Details
13.2.2 Boston Scientific Corporation (US) Business Overview
13.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
13.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2015-2020)
13.2.5 Boston Scientific Corporation (US) Recent Development
13.3 St. Jude Medical, Inc. (US)
13.3.1 St. Jude Medical, Inc. (US) Company Details
13.3.2 St. Jude Medical, Inc. (US) Business Overview
13.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
13.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.3.5 St. Jude Medical, Inc. (US) Recent Development
13.4 Synapse Biomedical, Inc. (US)
13.4.1 Synapse Biomedical, Inc. (US) Company Details
13.4.2 Synapse Biomedical, Inc. (US) Business Overview
13.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
13.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.4.5 Synapse Biomedical, Inc. (US) Recent Development
13.5 Nevro Corporation (US)
13.5.1 Nevro Corporation (US) Company Details
13.5.2 Nevro Corporation (US) Business Overview
13.5.3 Nevro Corporation (US) External Neuromodulation Introduction
13.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2015-2020)
13.5.5 Nevro Corporation (US) Recent Development
13.6 Neurosigma, Inc. (US)
13.6.1 Neurosigma, Inc. (US) Company Details
13.6.2 Neurosigma, Inc. (US) Business Overview
13.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
13.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.6.5 Neurosigma, Inc. (US) Recent Development
13.7 Neuropace, Inc. (US)
13.7.1 Neuropace, Inc. (US) Company Details
13.7.2 Neuropace, Inc. (US) Business Overview
13.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
13.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.7.5 Neuropace, Inc. (US) Recent Development
13.8 Neuronetics, Inc. (US)
13.8.1 Neuronetics, Inc. (US) Company Details
13.8.2 Neuronetics, Inc. (US) Business Overview
13.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
13.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.8.5 Neuronetics, Inc. (US) Recent Development
13.9 Cyberonics, Inc. (US)
13.9.1 Cyberonics, Inc. (US) Company Details
13.9.2 Cyberonics, Inc. (US) Business Overview
13.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
13.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2015-2020)
13.9.5 Cyberonics, Inc. (US) Recent Development
13.10 BioControl Medical (Israel)
13.10.1 BioControl Medical (Israel) Company Details
13.10.2 BioControl Medical (Israel) Business Overview
13.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
13.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2015-2020)
13.10.5 BioControl Medical (Israel) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. External Neuromodulation Key Market Segments
Table 2. Key Players Covered: Ranking by External Neuromodulation Revenue
Table 3. Ranking of Global Top External Neuromodulation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global External Neuromodulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transcutaneous Electrical Nerve Stimulation
Table 6. Key Players of Transcranial Magnetic Stimulation
Table 7. Key Players of Respiratory Electrical Stimulation
Table 8. Global External Neuromodulation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global External Neuromodulation Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global External Neuromodulation Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global External Neuromodulation Market Share by Regions (2015-2020)
Table 12. Global External Neuromodulation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global External Neuromodulation Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. External Neuromodulation Market Growth Strategy
Table 18. Main Points Interviewed from Key External Neuromodulation Players
Table 19. Global External Neuromodulation Revenue by Players (2015-2020) (Million US$)
Table 20. Global External Neuromodulation Market Share by Players (2015-2020)
Table 21. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in External Neuromodulation as of 2019)
Table 22. Global External Neuromodulation by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players External Neuromodulation Product Solution and Service
Table 25. Date of Enter into External Neuromodulation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 28. Global External Neuromodulation Market Size Share by Type (2015-2020)
Table 29. Global External Neuromodulation Revenue Market Share by Type (2021-2026)
Table 30. Global External Neuromodulation Market Size Share by Application (2015-2020)
Table 31. Global External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 32. Global External Neuromodulation Market Size Share by Application (2021-2026)
Table 33. North America Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 34. North America Key Players External Neuromodulation Market Share (2019-2020)
Table 35. North America External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 36. North America External Neuromodulation Market Share by Type (2015-2020)
Table 37. North America External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 38. North America External Neuromodulation Market Share by Application (2015-2020)
Table 39. Europe Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players External Neuromodulation Market Share (2019-2020)
Table 41. Europe External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 42. Europe External Neuromodulation Market Share by Type (2015-2020)
Table 43. Europe External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 44. Europe External Neuromodulation Market Share by Application (2015-2020)
Table 45. China Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 46. China Key Players External Neuromodulation Market Share (2019-2020)
Table 47. China External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 48. China External Neuromodulation Market Share by Type (2015-2020)
Table 49. China External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 50. China External Neuromodulation Market Share by Application (2015-2020)
Table 51. Japan Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players External Neuromodulation Market Share (2019-2020)
Table 53. Japan External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 54. Japan External Neuromodulation Market Share by Type (2015-2020)
Table 55. Japan External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 56. Japan External Neuromodulation Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players External Neuromodulation Market Share (2019-2020)
Table 59. Southeast Asia External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia External Neuromodulation Market Share by Type (2015-2020)
Table 61. Southeast Asia External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia External Neuromodulation Market Share by Application (2015-2020)
Table 63. India Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 64. India Key Players External Neuromodulation Market Share (2019-2020)
Table 65. India External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 66. India External Neuromodulation Market Share by Type (2015-2020)
Table 67. India External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 68. India External Neuromodulation Market Share by Application (2015-2020)
Table 69. Central & South America Key Players External Neuromodulation Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players External Neuromodulation Market Share (2019-2020)
Table 71. Central & South America External Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America External Neuromodulation Market Share by Type (2015-2020)
Table 73. Central & South America External Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America External Neuromodulation Market Share by Application (2015-2020)
Table 75. Medtronic, Inc. (US) Company Details
Table 76. Medtronic, Inc. (US) Business Overview
Table 77. Medtronic, Inc. (US) Product
Table 78. Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 79. Medtronic, Inc. (US) Recent Development
Table 80. Boston Scientific Corporation (US) Company Details
Table 81. Boston Scientific Corporation (US) Business Overview
Table 82. Boston Scientific Corporation (US) Product
Table 83. Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 84. Boston Scientific Corporation (US) Recent Development
Table 85. St. Jude Medical, Inc. (US) Company Details
Table 86. St. Jude Medical, Inc. (US) Business Overview
Table 87. St. Jude Medical, Inc. (US) Product
Table 88. St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 89. St. Jude Medical, Inc. (US) Recent Development
Table 90. Synapse Biomedical, Inc. (US) Company Details
Table 91. Synapse Biomedical, Inc. (US) Business Overview
Table 92. Synapse Biomedical, Inc. (US) Product
Table 93. Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 94. Synapse Biomedical, Inc. (US) Recent Development
Table 95. Nevro Corporation (US) Company Details
Table 96. Nevro Corporation (US) Business Overview
Table 97. Nevro Corporation (US) Product
Table 98. Nevro Corporation (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 99. Nevro Corporation (US) Recent Development
Table 100. Neurosigma, Inc. (US) Company Details
Table 101. Neurosigma, Inc. (US) Business Overview
Table 102. Neurosigma, Inc. (US) Product
Table 103. Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 104. Neurosigma, Inc. (US) Recent Development
Table 105. Neuropace, Inc. (US) Company Details
Table 106. Neuropace, Inc. (US) Business Overview
Table 107. Neuropace, Inc. (US) Product
Table 108. Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 109. Neuropace, Inc. (US) Recent Development
Table 110. Neuronetics, Inc. (US) Business Overview
Table 111. Neuronetics, Inc. (US) Product
Table 112. Neuronetics, Inc. (US) Company Details
Table 113. Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 114. Neuronetics, Inc. (US) Recent Development
Table 115. Cyberonics, Inc. (US) Company Details
Table 116. Cyberonics, Inc. (US) Business Overview
Table 117. Cyberonics, Inc. (US) Product
Table 118. Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 119. Cyberonics, Inc. (US) Recent Development
Table 120. BioControl Medical (Israel) Company Details
Table 121. BioControl Medical (Israel) Business Overview
Table 122. BioControl Medical (Israel) Product
Table 123. BioControl Medical (Israel) Revenue in External Neuromodulation Business (2015-2020) (Million US$)
Table 124. BioControl Medical (Israel) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global External Neuromodulation Market Share by Type: 2020 VS 2026
Figure 2. Transcutaneous Electrical Nerve Stimulation Features
Figure 3. Transcranial Magnetic Stimulation Features
Figure 4. Respiratory Electrical Stimulation Features
Figure 5. Global External Neuromodulation Market Share by Application: 2020 VS 2026
Figure 6. Spinal Cord Stimulation Case Studies
Figure 7. Deep Brain Stimulation Case Studies
Figure 8. Sacral Nerve Stimulation Case Studies
Figure 9. Others Case Studies
Figure 10. External Neuromodulation Report Years Considered
Figure 11. Global External Neuromodulation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global External Neuromodulation Market Share by Regions: 2020 VS 2026
Figure 13. Global External Neuromodulation Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global External Neuromodulation Market Share by Players in 2019
Figure 16. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in External Neuromodulation as of 2019
Figure 17. The Top 10 and 5 Players Market Share by External Neuromodulation Revenue in 2019
Figure 18. North America External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America External Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
内部神経調節の世界市場（～2026年） Market Analysis and Insights: Global Internal Neuromodulation Market The global Internal Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…
- 神経調節の世界市場（～2026年） Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incid…
- 脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…
- 仙骨神経刺激の世界市場（～2026年） Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product s…